Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))

Ritu Ojha, Kunal Nepali, Chun Han Chen, Kuo Hsiang Chuang, Tung Yun Wu, Tony Eight Lin, Kai Cheng Hsu, Min Wu Chao, Mei Jung Lai, Mei Hsiang Lin, Han Li Huang, Chao Di Chang, Shiow Lin Pan, Mei Chuan Chen, Jing Ping Liou

研究成果: 雜誌貢獻評論/辯論同行評審

1 引文 斯高帕斯(Scopus)

指紋

深入研究「Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))」主題。共同形成了獨特的指紋。

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions